Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | United States | $4.52B | 28,292,616 | 75.55% | 24.45% | Net Selling | Net Selling |
| TGTX | TG THERAPEUTICS INC | United States | $2.45B | 154,420,772 | 53.78% | 46.22% | Net Selling | Net Selling |
| SRPT | SAREPTA THERAPEUTICS INC | United States | $12.37B | 94,523,766 | 73.88% | 26.12% | Net Buying | Net Selling |
| GMAB | GENMAB A | Denmark | $19.00B | 66,074,535 | 70.53% | 0.00% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | United States | $15.82B | 189,879,803 | 97.46% | 1.62% | Net Selling | Net Selling |
| RPRX | ROYALTY PHARMA PLC | United States | $16.77B | 597,434,791 | 51.02% | 16.51% | Net Selling | Net Buying |
| VNDA | VANDA PHARMACEUTICALS INC | United States | $274.45M | 57,537,499 | 56.23% | 43.77% | Net Selling | Net Selling |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | United States | $1.72B | 56,791,861 | 61.03% | 38.97% | Net Selling | Net Selling |
| HALO | HALOZYME THERAPEUTICS INC | United States | $4.98B | 126,824,800 | 78.21% | 21.79% | Net Selling | Net Selling |
| CORT | CORCEPT THERAPEUTICS INC | United States | $2.49B | 104,112,088 | 30.65% | 69.35% | Net Buying | Net Buying |
| INCY | INCYTE CORP | United States | $11.89B | 224,540,751 | 79.30% | 20.70% | Net Selling | Net Buying |
| EXEL | EXELIXIS INC | United States | $6.39B | 291,292,704 | 88.76% | 4.24% | Net Selling | Net Buying |
| JAZZ | JAZZ PHARMACEUTICALS PLC | Ireland | $6.88B | 62,345,283 | 26.94% | 73.06% | Net Selling | Net Selling |
| TECH | BIO-TECHNE CORP | United States | $11.55B | 157,191,685 | 97.66% | 2.34% | Net Buying | Net Selling |
| PBYI | PUMA BIOTECHNOLOGY INC | United States | $238.63M | 48,207,162 | 55.20% | 44.43% | Net Selling | |
| BNTX | BIONTECH SE | Germany | $21.38B | 237,725,735 | 17.05% | 0.00% | ||
| AMLX | AMYLYX PHARMACEUTICALS INC | United States | $130.82M | 67,782,139 | 52.42% | 47.58% | Net Buying | Net Selling |
| CPRX | CATALYST PHARMACEUTICALS INC | United States | $1.79B | 117,863,258 | 71.64% | 16.33% | Net Buying | Net Buying |
| NVO | NOVO NORDISK A S | Denmark | $582.74B | 4,510,000,000 | 6.84% | 0.00% | ||
| MDXG | MIMEDX GROUP INC | United States | $1.08B | 147,603,955 | 42.42% | 57.58% | Net Buying | Net Selling |
| UTHR | UNITED THERAPEUTICS CORP | United States | $11.32B | 44,355,694 | 87.59% | 12.41% | Net Selling | Net Selling |
| REGN | REGENERON PHARMACEUTICALS INC | United States | $99.17B | 109,761,896 | 69.34% | 30.66% | Net Selling | Net Buying |
| VRTX | VERTEX PHARMACEUTICALS INC | United States | $103.88B | 258,307,816 | 90.91% | 1.48% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.